BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 14499735)

  • 1. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
    Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
    Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipids in anticancer therapy.
    PadrĂ³n JM
    Curr Med Chem; 2006; 13(7):755-70. PubMed ID: 16611065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Click reactions with functional sphingolipids.
    Fink J; Seibel J
    Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic effects of dietary and synthetic sphingolipids in androgen-independent (PC-3) prostate cancer cells.
    Kent KD; Clubbs EA; Harper WJ; Bomser JA
    Lipids; 2008 Feb; 43(2):143-9. PubMed ID: 18188632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial ceramides and sphingophospholipids induce apoptosis of human leukaemic cells.
    Minamino M; Sakaguchi I; Naka T; Ikeda N; Kato Y; Tomiyasu I; Yano I; Kobayashi K
    Microbiology (Reading); 2003 Aug; 149(Pt 8):2071-2081. PubMed ID: 12904547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity.
    Tserng KY; Griffin RL
    Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
    Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
    Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular targeting therapy for leukemia by sphingolipid ceramide].
    Okazaki T
    Rinsho Byori; 2005 May; 53(5):413-21. PubMed ID: 15966405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
    Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
    Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
    Gencer EB; Ural AU; Avcu F; Baran Y
    Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.
    Cakir Z; Saydam G; Sahin F; Baran Y
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):279-86. PubMed ID: 20401667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute activation of de novo sphingolipid biosynthesis upon heat shock causes an accumulation of ceramide and subsequent dephosphorylation of SR proteins.
    Jenkins GM; Cowart LA; Signorelli P; Pettus BJ; Chalfant CE; Hannun YA
    J Biol Chem; 2002 Nov; 277(45):42572-8. PubMed ID: 12200446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
    Ghandour B; Dbaibo G; Darwiche N
    Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide.
    Sweeney EA; Inokuchi J; Igarashi Y
    FEBS Lett; 1998 Mar; 425(1):61-5. PubMed ID: 9541007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.